Abstract:Liver fibrosis affects millions of people worldwide and is rising vastly over the past decades. With no viable therapies available, liver transplantation is the only curative treatment for advanced diseased patients. Excessive accumulation of aberrant extracellular matrix (ECM) proteins, mostly collagens, produced by activated hepatic stellate cells (HSCs), is a hallmark of liver fibrosis. Several studies have suggested an inverse correlation between collagen-I degrading matrix metalloproteinase-1 (MMP-1) serum levels and liver fibrosis progression highlighting reduced MMP-1 levels are associated with poor disease prognosis in patients with liver fibrosis. We hypothesized that delivery of MMP-1 might potentiate collagen degradation and attenuate fibrosis development. In this study, we report a novel approach for the delivery of MMP-1 using MMP-1 decorated polymersomes (MMPsomes), as a surface-active vesicle-based ECM therapeutic, for the treatment of liver fibrosis. The storage-stable and enzymatically active MMPsomes were fabricated by a post-loading of Psomes with MMP-1. MMPsomes were extensively characterized for the physicochemical properties, MMP-1 surface localization, stability, enzymatic activity, and biological effects. Dose-dependent effects of MMP-1, and effects of MMPsomes versus MMP-1, empty polymersomes (Psomes) and MMP-1 + Psomes on gene and protein expression of collagen-I, MMP-1/TIMP-1 ratio, migration and cell viability were examined in TGFβ-activated human HSCs. Finally, the therapeutic effects of MMPsomes, compared to MMP-1, were evaluated in vivo in carbon-tetrachloride (CCl4)-induced early liver fibrosis mouse model. MMPsomes exhibited favorable physicochemical properties, MMP-1 surface localization and improved therapeutic efficacy in TGFβ-activated human HSCs in vitro. In CCl4-induced early liver fibrosis mouse model, MMPsomes inhibited intra-hepatic collagen-I (ECM marker, indicating early liver fibrosis) and F4/80 (marker for macrophages, indicating liver inflammation) expression. In conclusion, our results demonstrate an innovative approach of MMP-1 delivery, using surface-decorated MMPsomes, for alleviating liver fibrosis.

Dynamic Expression of MMP-13,MMP-2,MT-MMP2 in Reversal of Experimental Hepatic Fibrosis in Rats

Expression Pattern of Matrix Metalloproteinases-13 in a Rat Model of Alcoholic Liver Fibrosis.

Integrated Analysis of Hepatic Mirna and Mrna Expression Profiles in the Spontaneous Reversal Process of Liver Fibrosis.

Gene Expression Profile Analysis of the Spontaneous Reversal of Rat Hepatic Fibrosis by Cdna Microarray

Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis

Relationship Between Matrix Metalloproteinase-1,Tissue Inhibitor of Metalloproteinase-1 and Matrix Transition in Experimental Rat Liver Fibrosis and Influence of Kangxian Ruangan Granule on Them

Effect of Interleukin-10 and Platelet-Derived Growth Factor on Expressions of Matrix Metalloproteinases-2 and Tissue Inhibitor of Metalloproteinases-1 in Rat Fibrotic Liver and Cultured Hepatic Stellate Cells

Matrix metalloproteinase functions in hepatic injury and fibrosis

Therapeutic Effect and Location of GFP-Labeled Placental Mesenchymal Stem Cells on Hepatic Fibrosis in Rats

Matrix Metalloproteinases, the Pros and Cons, in Liver Fibrosis

Dynamic Changes of Key Metabolites During Liver Fibrosis in Rats.

Dynamic Changes in MMP1 and TIMP1 in the Antifibrotic Process of Dahuang Zhechong Pill in Rats with Liver Fibrosis

Kupffer-Derived Matrix Metalloproteinase-9 Contributes To Liver Fibrosis Resolution

The Role of Mesenchymal Stem Cells and Imatinib in the Process of Liver Fibrosis Healing Through CCL2-CCR2 and CX3CL1-CX3CR1 Axes

Production and activity of matrix metalloproteinases during liver fibrosis progression of chronic hepatitis C patients

Integration of high‑throughput data of microRNA and mRNA expression profiles reveals novel insights into the mechanism of liver fibrosis.

Epigenetic Histone Methylation Regulates Mmp-1 Expression In Myofibroblastic Hepatic Stellate Cell

[Expression of Matrix Metalloproteinase-2 in Rat Pulmonary Fibrosis].

Mest attenuates CCl4-induced liver fibrosis in rats by inhibiting the Wnt/β-catenin signaling pathway.

Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis

Matrix metalloproteinase-1 decorated polymersomes, a surface-active extracellular matrix therapeutic, potentiates collagen degradation and attenuates early liver fibrosis